Fig. 3From: Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitisComparison of clinical efficacy between the ECRS and non-ECRS groups. All results are expressed as individual data, and the boxes represent medians and interquartile ranges. The upper and lower whiskers represent the 90th and 10 percentiles, respectively. a Change from baseline in oral corticosteroid dose. b Change from baseline in FeNO. †Mann-Whitney U testBack to article page